Institutional Ownership Inmune Bio, Inc. (INMB)
This table provides information about the institutional ownership of Inmune Bio, Inc. (INMB). We have compiled data on the 61 institutions that hold shares in the stock, with a total of 4.66 Million shares, which have been reported (via 13F filing form) to have a value of $24.3 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Clearstead Advisors, LLC
Cleveland, OH |
Aug 09, 2024 Q2 2024 |
490
shares
|
$2,641
0.0% of portfolio
|
Q1 2024
Added 16.67%
|
|
Amalgamated Bank
New York, NY |
Aug 12, 2024 Q2 2024 |
422
shares
|
$2,274
0.0% of portfolio
|
Q2 2024
New holding
|
|
Federation Des Caisses Desjardins Du Quebec
Levis, A8 |
Aug 14, 2024 Q2 2024 |
400
shares
|
$2,156
0.0% of portfolio
|
Q1 2021
Reduced 50.0%
|
|
Nbc Securities, Inc.
Birmingham, AL |
Jul 10, 2024 Q2 2024 |
270
shares
|
$1,455
0.0% of portfolio
|
Q3 2023
New holding
|
|
Ifp Advisors, Inc
|
Jul 30, 2024 Q2 2024 |
184
shares
|
$991
0.0% of portfolio
|
Q1 2023
Reduced 50.0%
|
|
Cordasco Financial Network
|
Jul 15, 2022 Q2 2022 |
100
shares
|
$539
0.0% of portfolio
|
Q1 2022
New holding
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Jul 23, 2024 Q2 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q2 2024
New holding
|